ClearPoint Health Welcomes New Stop Loss Executive

Juli Frink has recently joined ClearPoint Health as the vice president of their Stop Loss Center of Excellence, becoming a part of their executive leadership team. In a statement on LinkedIn, she expressed her excitement for this new opportunity to work with the talented team at ClearPoint Health and contribute to their strategic growth goals and the expansion of self-funding opportunities in the market.

Prior to joining ClearPoint Health, Frink served as the director of commercial market product strategy at Aetna, a CVS Health Company, from July 2019 to February 2024 in Jacksonville, Florida. During her time at Florida Blue from February 2007 to July 2019, she held the position of senior program manager for stop loss and reinsurance. In this role, Frink provided leadership in developing, launching, and operating profitable stop loss and reinsurance administration through a partnership model. She also played a key role in developing and implementing growth and retention strategies with measurable impact.

Frink highlighted the importance of captive insurance skills in her new role at ClearPoint Health. She is excited to bring her expertise in product development and strategic planning to help drive the company’s growth and success. With over 15 years of experience in the insurance industry, Frink is confident that she will be able to make meaningful contributions to ClearPoint Health’s executive leadership team.

By Sophia Gonzalez

As a content writer at, I am dedicated to crafting engaging stories that captivate our readers. With a knack for turning complex topics into accessible and compelling narratives, I weave words together to inform and inspire. My passion lies in delivering accurate and thought-provoking content that keeps our audience informed and entertained. From breaking news stories to in-depth features, I strive to bring a fresh perspective to every piece I create. Join me on this journey of exploration and discovery through the power of words at

Leave a Reply